— Know what they know.
Not Investment Advice
Also trades as: PRE (NASDAQ) · $vol 3M

PRENW NASDAQ

Prenetics Global Limited
1W: +0.0% 1M: +8.3% 3M: -20.1% YTD: -34.3% 1Y: +32.6% 3Y: -97.7%
$0.02
+0.00 (+0.00%)
 
Weekly Expected Move ±35.1%
$0 $0 $0 $0 $0
NASDAQ · Healthcare · Medical - Diagnostics & Research · Alpha Radar Sell · Power 49 · $250158 mcap · 39344 float · 103.99% daily turnover · Short 88% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.3M
52W Range0.0177-0.022
Volume0
Avg Volume40,914
Beta0.15
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOSheng Wu Yeung
Employees285
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2021-07-16
Unit 701-706, K11 Atelier King’s Road
Quarry Bay
HK
852 2210 9588
About Prenetics Global Limited

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Recent Insider Trades

NameTypeSharesPriceDate
Shah Darshan Ravindr 0 2026-03-26
Shah Darshan Ravindr 5,599 2026-03-26
Yeung Danny Sheng Wu 0 2026-03-26
Yeung Danny Sheng Wu 0 2026-03-26
Yeung Danny Sheng Wu 0 2026-03-26

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms